DDL Expands GMP Laboratory Expertise with the Addition of Amy Miller and Bob Anderson

 New leadership strengthens scientific support and laboratory operations for the life sciences
industry and drug delivery testing

EDEN PRAIRIE, Minn., Oct. 21, 2026 /PRNewswire/ -- DDL, a third-party testing laboratory, is pleased to announce the addition of Amy Miller as Senior Director, Lab Support Services & Scientific Affairs, and Bob Anderson as Director, Lab Operations. Their combined expertise supports the continued expansion of DDL's GMP testing services and laboratory operations for the life sciences industry and drug delivery testing.

Amy brings 28 years of experience as a technical and strategic analytical and marketing leader in global pharmaceutical component and medical device manufacturing, service partnerships, and CDMO environments. Throughout her career, she has built and led high-performing global teams, simplified business processes, and aligned cross-functional stakeholders around strategic priorities. Her expertise in analytical services strategy will help DDL expand its testing services to address evolving pharmaceutical packaging and drug delivery needs.

Bob has 30 years of experience in pharmaceutical product development, analytical chemistry and cGMP laboratory operations. He has extensive experience building high-performing teams, forging client partnerships and delivering complex programs. Bob's analytical testing expertise has focused on inhalation, transdermal and microneedle delivery platforms from early-stage development through regulatory submission and post-approval support.

"Adding Amy and Bob strengthens the scientific expertise and operational leadership behind our growing GMP laboratory," said Jennifer Riter, Vice President of Analytical Testing Services at DDL. "Their experience will help us expand our capabilities and support customers facing complex pharmaceutical containment, packaging and drug delivery testing challenges."

The appointments build on DDL's investment in GMP testing and pharmaceutical consulting services. DDL offers GMP testing services in its FDA-registered laboratory in Minnetonka, MN (near its Eden Prairie, Minnesota headquarters). The facility provides ICH stability studies, functional and mechanical performance testing, container closure integrity testing (CCIT) and simulated distribution testing for products such as auto-injectors, prefilled syringes, inhalers, and other drug-device combination products strengthening DDL's ability to deliver regulatory-compliant testing services to pharmaceutical, biotech, and medical device customers.

For further information regarding DDL's GMP testing and consulting services, or to request a quote, please visit www.DDLtesting.com or contact us directly at 800-229-4235.

About DDL 

DDL is a third party independent testing facility that offers expertise in medical device, combination products, materials and package testing primarily serving the life sciences industry. DDL's testing laboratories are located in Eden Prairie, MN, Minnetonka, MN, Irvine, CA and Edison, NJ. Visit www.DDLTesting.com for more information about the testing services offered by DDL.

SOURCE DDL, INC.